Atlas FDA

TANDEM-R PSA IMMUNORADIOMETRIC ASSAY

FDA premarket approval P850048/S043 · decided 2016-11-09

Approval details

PMA number
P850048
Supplement
S043
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TANDEM-R PSA IMMUNORADIOMETRIC ASSAY
Generic name
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
Applicant
Beckman Coulter, Inc.
Date received
2016-10-11
Decision date
2016-11-09
Days to decision
29 days
Decision code
OK30
Product code
MTF
Advisory committee
Immunology
Expedited review
No
Location
Brea, CA
Statement
Change in the manufacturing process for the conversion from a Hollow Fiber particle coupling process to a Semi-Automated Magnetic separation particle coupling process used for the paramagnetic particles in the Access Hybritech PSA.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20